X

Drug Profile

ALA derivatives - PhotoCure

Alternative Names: Aminolevulinate derivatives - PhotoCure

Latest Information Update: 17 Feb 2009

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator PhotoCure
Developer Photocure
Class Amino acids; Keto acids; Levulinic acids; Small molecules
Mechanism of Action Photosensitisers

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued Brain cancer; Breast cancer; Colorectal cancer; Gynaecological cancer; Head and neck cancer; High-grade oesophageal dysplasia

Most Recent Events

29 Apr 2005 Discontinued - Phase-I for Head and neck cancer in Norway (unspecified route)
29 Apr 2005 Discontinued - Phase-I for High-grade oesophageal dysplasia in Norway (unspecified route)
15 Apr 2003 Phase-I clinical trials in Gynaecological cancer in Germany (unspecified route)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com